Clinical trials
Observational Myocardial Infarction trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 5 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tomsk National Research Medical Center of the Russian Academy of Sciences | 3 |
| AstraZeneca | 1 |
| Center for Strategic Planning, of the Federal Medical and Biological Agency | 1 |
| Closed Joint-Stock Company NeoCor | 1 |
| Eurasian Association of Therapists | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 1 |
| National Medical Research Center for Therapy and Preventive Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
| Novosibirsk State Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 16 |
| Heart Failure | 3 |
| Stroke | 3 |
| Arrhythmias, Cardiac | 2 |
| Atrial Fibrillation | 2 |
| COVID-19 | 2 |
| Coronary Artery Disease | 2 |
| Inflammation | 2 |
| Ischemic Stroke | 2 |
| Pulmonary Embolism | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.